No Detail Found!

Effect of post-discharge pharmacist-led follow-up on drug treatment in patients with deep venous thrombosis in primary hospitals in China

Author(s)
Xiaojin Liu Department of Drug Clinical Trial Center, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Quan Xiao Department of Drug Clinical Trial Center, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Yun Li Department of Traditional Chinese Medicine Department, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Guobing Hu Department of Pharmacy, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Wang Kun Department of Pharmacy, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Wanbo Xu Department of Radiology, QiLu Hospital of Shandong University Dezhou Hospital,Dezhou, Shandong,China
Abstract
Warfarin and rivaroxaban were the two most commonly-used anticoagulant drugs for Deep venous thrombosis (DVT). The aim of this study was to explore the effects of post-discharge pharmacist-led follow-up on drug treatment in patients with DVT in primary hospitals from a pharmacological perspective. A total of 125 patients were recruited from July 2017 to June 2019 and randomized to either a control group or an intervention group. The control group was given routine medication guidance, clinical pharmacists followed up at 3 and 6 months after discharge. The intervention group was based on the control group and was followed up weekly for 6 months after discharge. For patients taking warfarin, the percentage of time in therapeutic range (TTR) and TTR =65% were significantly higher in the intervention group (p<0.05) and they also had less frequent dose changes. For patients taking warfarin or rivaroxaban, vascular ultrasonography showed better improvement rate in the intervention group (p<0.05). Pharmacist-led follow-up showed that the medication adherence (p<0.05) were significantly improved. There were lower risks of total and minor hemorrhage events and thrombosis events in the intervention group (p<0.05). Pharmacist-led follow-up not only reduced the risk of hemorrhage and thrombosis events, but also improved adherence to anticoagulation drugs.
Publication Details
Page(s) 785-791
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Medication Adherence, pharmacist, Deep venous thrombosis, Primary hospital, follow-up
0

Citations

0

Downloads

69

Views